Back

Poolbeg Pharma secures funding through Q2 2028 for POLB 001 trials

Verifying
  • Poolbeg Pharma secured funding to complete its clinical trials through Q2 2028.
  • Poolbeg Pharma is recruiting patients for the TOPICAL trial of POLB 001.
  • POLB 001 is aimed at preventing cytokine release syndrome in cancer p...
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.